Macquarie Group
PGEN icon

Macquarie Group’s Precigen PGEN Stock Holding History

Macquarie Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-55,427
Closed -$362K – 1941
2018
Q4 		$362K Buy
55,427
+1,743
+3% +$19.5K ﹤0.01% 1341
2018
Q3 		$924K Sell
53,684
-9,055
-14% -$135K ﹤0.01% 1217
2018
Q2 		$875K Buy
62,739
+22,869
+57% +$386K ﹤0.01% 1218
2018
Q1 		$611K Sell
39,870
-361
-0.9% -$5.16K ﹤0.01% 1323
2017
Q4 		$463K Buy
40,231
+4,236
+12% +$63.1K ﹤0.01% 1464
2017
Q3 		$684K Buy
35,995
+7,353
+26% +$151K ﹤0.01% 1328
2017
Q2 		$690K Sell
28,642
-3,260
-10% -$71.5K ﹤0.01% 1252
2017
Q1 		$632K Buy
31,902
+4,547
+17% +$102K ﹤0.01% 1277
2016
Q4 		$659K Sell
27,355
-554
-2% -$15.4K ﹤0.01% 1269
2016
Q3 		$775K Sell
27,909
-27,790
-50% -$735K ﹤0.01% 1212
2016
Q2 		$1.36M Buy
+55,699
New +$1.58M ﹤0.01% 1224
2015
Q3 		– Sell
-4,036
Closed -$195K – 1635
2015
Q2 		$195K Buy
+4,036
New +$170K ﹤0.01% 1451

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Macquarie Group's PGEN Position: Q1 2019 in Review

Macquarie Group sold out of Precigen (PGEN) in Q1 2019, closing a stake of 55,427 shares — an estimated $362K sold.

Macquarie Group first reported a position in PGEN in Q2 2015 and held it in 12 quarters. The position peaked at $1.36M in Q2 2016. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

  • Macquarie Group reported no remaining Precigen position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 55,427 Precigen shares in Q1 2019, an estimated $362K.
  • Macquarie Group first reported a position in Precigen in Q2 2015 and held it in 12 quarters.
  • Macquarie Group's Precigen position peaked at $1.36M in Q2 2016.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.